Drew Moghanaki, Professor, Chief of Thoracic Oncology at the Department of Radiation Oncology and Stanley Iezman and Nancy Stark Endowed Chair in Thoracic Radiation Oncology Research at David Geffen School of Medicine at UCLA, and Chief Medical Officer of Respirati, shared on X:
“The thoracic surgery, medical, and radiation oncology team at the University of Pennsylvania presents their single-institutional experience at ASTRO25 for patients with LA-NSCLC treated with neoadjuvant chemo-ICI, of whom 42% didn’t proceed to surgery.”
More posts featuring Drew Moghanaki.